KR100863758B1 - 항문직장 장애의 치료 조성물 및 방법 - Google Patents

항문직장 장애의 치료 조성물 및 방법 Download PDF

Info

Publication number
KR100863758B1
KR100863758B1 KR1020037001579A KR20037001579A KR100863758B1 KR 100863758 B1 KR100863758 B1 KR 100863758B1 KR 1020037001579 A KR1020037001579 A KR 1020037001579A KR 20037001579 A KR20037001579 A KR 20037001579A KR 100863758 B1 KR100863758 B1 KR 100863758B1
Authority
KR
South Korea
Prior art keywords
anal
delete delete
sphincter
pde
iasp
Prior art date
Application number
KR1020037001579A
Other languages
English (en)
Korean (ko)
Other versions
KR20030024826A (ko
Inventor
파크스토마스피.
맥비비언
리정-청
리찰스
Original Assignee
셀러지 파마세우티칼스, 인크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 셀러지 파마세우티칼스, 인크 filed Critical 셀러지 파마세우티칼스, 인크
Publication of KR20030024826A publication Critical patent/KR20030024826A/ko
Application granted granted Critical
Publication of KR100863758B1 publication Critical patent/KR100863758B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
KR1020037001579A 2000-07-31 2001-07-30 항문직장 장애의 치료 조성물 및 방법 KR100863758B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22226700P 2000-07-31 2000-07-31
US60/222,267 2000-07-31
PCT/US2001/023971 WO2002009714A1 (en) 2000-07-31 2001-07-30 Compositions and methods for the treatment of anorectal disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020087015829A Division KR20080068145A (ko) 2000-07-31 2001-07-30 항문직장 장애의 치료 조성물 및 방법

Publications (2)

Publication Number Publication Date
KR20030024826A KR20030024826A (ko) 2003-03-26
KR100863758B1 true KR100863758B1 (ko) 2008-10-16

Family

ID=22831555

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020097025777A KR20100017750A (ko) 2000-07-31 2001-07-30 항문직장 장애의 치료 조성물 및 방법
KR1020037001579A KR100863758B1 (ko) 2000-07-31 2001-07-30 항문직장 장애의 치료 조성물 및 방법
KR1020087015829A KR20080068145A (ko) 2000-07-31 2001-07-30 항문직장 장애의 치료 조성물 및 방법

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020097025777A KR20100017750A (ko) 2000-07-31 2001-07-30 항문직장 장애의 치료 조성물 및 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020087015829A KR20080068145A (ko) 2000-07-31 2001-07-30 항문직장 장애의 치료 조성물 및 방법

Country Status (8)

Country Link
EP (1) EP1315499A4 (es)
JP (1) JP2004516244A (es)
KR (3) KR20100017750A (es)
AU (1) AU2001279104A1 (es)
CA (1) CA2417848A1 (es)
IL (1) IL154202A0 (es)
MX (1) MXPA03000931A (es)
WO (1) WO2002009714A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010151004A2 (ko) 2009-06-23 2010-12-29 Yeo Oh-Young 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0020588D0 (en) * 2000-08-21 2000-10-11 Pfizer Ltd Treatment of wounds
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
CN102145004B (zh) * 2010-02-09 2012-03-21 鲁南制药集团股份有限公司 己酮可可碱在制备预防或治疗功能性便秘的药物中的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595753A (en) 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1298309A (zh) * 1998-02-27 2001-06-06 同步神经元有限责任公司 治疗肛门区疼痛的方法及其组合物
AU764921B2 (en) * 1998-12-14 2003-09-04 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595753A (en) 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010151004A2 (ko) 2009-06-23 2010-12-29 Yeo Oh-Young 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물

Also Published As

Publication number Publication date
IL154202A0 (en) 2003-07-31
JP2004516244A (ja) 2004-06-03
CA2417848A1 (en) 2002-02-07
WO2002009714A1 (en) 2002-02-07
AU2001279104A1 (en) 2002-02-13
WO2002009714A9 (en) 2003-03-06
EP1315499A4 (en) 2007-09-05
MXPA03000931A (es) 2004-08-12
KR20080068145A (ko) 2008-07-22
KR20030024826A (ko) 2003-03-26
KR20100017750A (ko) 2010-02-16
EP1315499A1 (en) 2003-06-04

Similar Documents

Publication Publication Date Title
US6391869B1 (en) Compositions and methods for the treatment of anorectal disorders
US6627632B2 (en) Compositions and methods for the treatment of anorectal disorders
US6395736B1 (en) Compositions and methods for the treatment of anorectal disorders
AU2003213787A8 (en) Compositions and methods for the treatment of anorectal disorders
US6987129B2 (en) Compounds and methods for the treatment of urogenital disorders
JP4097285B2 (ja) 種々の頑固な疾患の治療のための医薬の製造に有用な組成物
US20030212139A1 (en) Methods, compositions, and kits for enhancing female sexual desire and responsiveness
KR100863758B1 (ko) 항문직장 장애의 치료 조성물 및 방법
JP2001504484A (ja) ネファゾドンの外傷後ストレス障害における使用
AU774064B2 (en) Compositions and methods for the treatment of anorectal disorders
JP2007056042A (ja) 肛門直腸障害の処置のための組成物および方法
ZA200104778B (en) Compositions and methods for the treatment of anorectal disorders.
MXPA01005733A (es) Composiciones y metodos para el tratamiento de trastornos anorrectales
CA2009402A1 (en) Use of benzydamine and salts thereof for relief of pain associated with herpes viral infections and laser vaporization of condylomata
AU2010227094A1 (en) Compounds and methods for the treatment of urogenital disorders
Lieberman Modulation of penile blood flow through vasoactive agents
AU2002254142A1 (en) Compounds and methods for the treatment of urogenital disorders

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
J201 Request for trial against refusal decision
A107 Divisional application of patent
B701 Decision to grant
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee